Abstract LB123: Spatial immune architecture at single-cell resolution predicts response to atezolizumab plus bevacizumab in advanced HCC
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Anna Vila-Escoda, Marta Piqué-Gili, Marta Casado-Pelaez, Roser Pinyol, Ana Hernández de Sande, Verónica Davalos, Albert Gris-Oliver, Carla Montironi, Judit Peix, Daniela Grases, Ezequiel Mauro, Guillem Cano-Segarra, Sarah Cappuyns, Igor Figueiredo, Giorgio Ioannou, Edgar Gonzalez-Kozlova, Tim Meyer, Anja Lachenmayer, Jens U Marquardt, Helen L Reeves, Julien Edeline, Fabian Finkelmeier, Jörg Trojan, Sacha Gnjatic, Jean-Frederic Blanc, Richard A Hubner, Matthias Pinter, Tom Luedde, Arndt Vogel, Daniela Sia, Vincenzo Mazzaferro, Manel Esteller, Jeroen Dekervel, Eduard Porta-Pardo, Josep M Llovet
Institutions: Hospital Clínic de Barcelona, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Josep Carreras Leukaemia Research Institute, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Universitair Ziekenhuis Leuven, The Royal Free Hospital, University College London, University of Bern, University Hospital of Bern, University of Lübeck, NIHR Newcastle Biomedical Research Centre, Centre Eugène Marquis, Goethe University Frankfurt, University Hospital Frankfurt, Centre Hospitalier Universitaire de Bordeaux, The Christie Hospital, The Christie NHS Foundation Trust, Medical University of Vienna, Düsseldorf University Hospital, Heinrich Heine University Düsseldorf, Medizinische Hochschule Hannover, University of Milan, Fondazione IRCCS Istituto Nazionale dei Tumori, Institució Catalana de Recerca i Estudis Avançats, KU Leuven, Barcelona Supercomputing Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7154697271
Cites:
Cited by:
Related to: